Shlevin Harold H.

CIK 00015570821 companyNORCROSS, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001557082

Recent Transactions

50 trades

Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2026-01-16+60,000→ 60,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$1.98/sh+20,000→ 31,206 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$7.04/sh−19,793→ 11,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-12-17−20,000→ 0 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$7.04/sh−4,706→ 6,500 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-12-15−8,417→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stok
2025-12-15$4.16/sh+8,417→ 19,623 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-15$6.30/sh−8,417→ 11,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-12-12−19,793→ 53,417 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-12$6.27/sh−19,793→ 11,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-12$4.16/sh+19,793→ 30,999 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-09$4.16/sh+16,790→ 27,996 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-12-09−16,790→ 73,210 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-09$6.27/sh−16,790→ 11,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-12-08$1.98/sh+20,000→ 31,206 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-08$5.95/sh−35,000→ 11,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-08$2.11/sh+20,000→ 31,206 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-08$5.96/sh−20,000→ 11,206 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-12-08$5.96/sh−20,000→ 11,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-08$1.72/sh+25,000→ 36,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-12-08−20,000→ 20,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-12-08−35,000→ 35,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-12-08−25,000→ 25,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-12-08−20,000→ 20,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-12-08−35,000→ 35,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-08$5.95/sh−25,000→ 11,206 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-08$6.00/sh−4,000→ 11,206 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-08$2.86/sh+35,000→ 46,206 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-01-23+60,000→ 60,000 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-12-30$1.16/sh+6,500→ 15,206 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2023-01-26+40,000→ 40,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2022-01-24+40,000→ 40,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2021-03-25+70,000→ 70,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2021-03-25+40,000→ 40,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2020-01-09+70,000→ 70,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2019-06-04$1.37/sh+8,706→ 8,706 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2019-06-04−8,706→ 29,294 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2019-01-16+70,000→ 70,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-13+25,544→ 30,918 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-13$7.79/sh−30,918→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-06-13−25,544→ 12,456 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-12$6.50/sh−12,780→ 5,374 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-11$6.50/sh−10,760→ 18,154 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-08$1.37/sh+29,294→ 184,099 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-06-08−50,000→ 0 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-06-08+35,000→ 35,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-08$5.77/sh−104,294→ 28,914 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-08$0.87/sh+50,000→ 103,914 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-06-08−29,294→ 8,706 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-06-07−75,190→ 0 total

Companies

GALECTIN THERAPEUTICS INC
Director
$GALT

Recent Filings

Address

4960 PEACHTREE INDUSTRIAL BLVD SUITE 240

NORCROSS, GA, 30071

View on SEC.gov